J Mol Cell Biol 13(10):728738 Nair S, Ormazabal V, Carrion F, Handberg A, McIntyre HD, Salomon C (2023) Extracellular vesicle-mediated targeting strategies for long-term health benefits in gestational diabetes
Compounded medications are not FDA-approved This is a critical disclosure that applies to every provider in this category, including Brello
While both tirzepatide and semaglutide cause GI side effects , the specific profile differs, and some patients who do not tolerate one may tolerate the other
A prospective study involving 112 patients with severe obesity treated with semaglutide demonstrated that sex is a key predictor of therapeutic effect, with women showing significantly higher weight loss rates than men [78]
Cureus 16 , e59319 (2024)